CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Cash flows from operating activities:
Net loss before non-controlling interest	$ (1,908)	$ (4,848)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	15	42
Amortization of intangible assets	17	0
Amortization of convertible note discount	43	0
Amortization of deferred financing costs	33	0
Stock-based compensation expense	229	191
Loss on disposal of property and equipment	2	0
Assignment of Medicsight's stock	0	(4)
Gain on sale of loan receivable - related party	0	(81)
(Increase)/decrease in assets
Accounts receivable	72	(176)
Other receivables - related party	0	47
Proceeds from release of security deposits	140	0
Prepaid expenses and other current assets	241	(337)
Inventory	36	0
Increase/(decrease) in liabilities
Accounts payable	71	197
Accrued expenses	(5)	(154)
Other payables	(23)	0
Net cash used in operating activities	(1,037)	(5,123)
Cash flows from investing activities:
Purchase of property and equipment	(12)	0
Purchase of intangible asset	(200)	0
Repayment of Dunamis loan	0	1,100
Receipts from sale of Moneygate	0	401
Receipts of deferred consideration for sale of assets	0	370
Receipts from sale of Medicsight's stock	0	110
Net cash (used in)/provided by investing activities	(212)	1,981
Cash flows from financing activities:
Cash paid in lieu of fractional shares in reverse/forward split	(5)	0
Proceeds from issuance of convertible note	3,500	0
Payments for convertible note issuance costs	(372)	0
Net cash provided by financing activities	3,123	0
Effects of exchange rates on cash and cash equivalents	80	412
Net change in cash and cash equivalents	1,954	(2,730)
Cash and cash equivalents, beginning of period	3,704	8,434
Cash and cash equivalents, end of period	5,658	5,704
Supplemental non-cash disclosures (investing and financing activities):
Stock issued for services in connection with issuance of convertible note	315	0
Warrants issued in connection with acquisition of intangible assets	800	0
Warrants issued in connection with issuance of convertible note	500	0
Beneficial conversion on convertible note	500	0
Intangible asset contributed by non-controlling interest	$ 819	$ 0